
Masimo (MASI) Stock Forecast & Price Target
Masimo (MASI) Analyst Ratings
Bulls say
Masimo is an innovative and growing medical technology company that is focused on developing and providing noninvasive patient monitoring technologies, hospital automation and connectivity solutions, and other healthcare products. The company's core business segment, healthcare, is a key revenue driver and is expected to continue to grow due to Masimo's focus on innovation and execution. Their recent investor day showcased their progress in optimizing their cost structure, closing a sale of a non-core business, and highlighting their growth pillars, including focus, innovation and execution. With a target of generating $1B of free cash flow and an expected 30% operating margin, Masimo is well-positioned for long-term success.
Bears say
Masimo is heavily dependent on the healthcare sector for its revenues, putting them at risk of experiencing significant financial challenges if there are any disruptions in the industry. Additionally, their recent refinancing of their credit agreement and focus on growth markets through investment in advanced technologies may not be enough to offset the potential negative impacts on their business. The pending acquisition by Danaher for $9.9B also raises concerns about their future performance and potential for competing bids.
This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.
Masimo (MASI) Analyst Forecast & Price Prediction
Start investing in Masimo (MASI)
Order type
Buy in
Order amount
Est. shares
0 shares